|
gptkb:Programmed_cell_death_protein_1
|
gptkb:pembrolizumab
|
|
gptkb:SARS-CoV-2_3CL_protease
|
COVID-19 antivirals
|
|
gptkb:SSTR3
|
gptkb:somatostatin_analogs
|
|
gptkb:PLCB4
|
no approved drugs
|
|
gptkb:GLP-1_receptor
|
anti-obesity drugs
|
|
gptkb:Cyclin-dependent_kinase_4
|
gptkb:abemaciclib
|
|
gptkb:F9_gene
|
hemophilia B treatment
|
|
gptkb:Sodium-dependent_serotonin_transporter
|
antidepressants
|
|
gptkb:Cdk6
|
gptkb:palbociclib
|
|
gptkb:JAK_kinases
|
gptkb:baricitinib
|
|
gptkb:TNFA_HUMAN
|
Golimumab
|
|
gptkb:ADRA2A_gene
|
gptkb:yohimbine
|
|
gptkb:MAO-B
|
antiparkinsonian drugs
|
|
gptkb:beta-adrenergic_receptor
|
beta agonist
|
|
gptkb:BRAF_V600E_mutant_protein
|
gptkb:vemurafenib
|
|
gptkb:sphingosine-1-phosphate_receptor_1
|
gptkb:ozanimod
|
|
gptkb:Estrogen_receptor_alpha
|
raloxifene
|
|
gptkb:Histamine_H3_receptor
|
gptkb:Alzheimer's_disease
|
|
gptkb:Braf
|
gptkb:sorafenib
|
|
gptkb:adrenoceptor_beta_2,_surface
|
gptkb:salmeterol
|